Clinical Trial Update: A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

View source ↗

Summary

Completed clinical trial assessing how long rheumatoid arthritis patients maintain efficacy after stopping tocilizumab therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Rheumatoid Arthritis | Status: COMPLETED